Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Alkermes Integrates EDT, Announces Manufacturing Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Alkermes Integrates EDT, Announces Manufacturing Pact

Athlone site to make drug for top pharma

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Alkermes plc has established corporate operations in Ireland, with headquarters located in Dublin. The company, including its HQ and operations in Athlone, County Westmeath, has more than 450 employees based in Ireland and more than 1,200 employees worldwide. Alkermes plc was created following the merger of Alkermes, Inc. with Elan Drug Technologies (EDT), the profitable, world-class drug formulation and manufacturing business unit that was formerly a part of Elan Corporation, plc.

Alkermes has also announced a multiyear, multimillion dollar manufacturing agreement with “one of the world’s top ten pharmaceutical companies,” according to a company statement. Alkermes will manufacture the company’s finished pharmaceutical product, which will be produced at the Athlone, Ireland facility. The company projects $15 million to $20 million in annual manufacturing revenues by 2016 from this deal.

“We are a strong, global company with a diversified product portfolio, and we look forward to accelerating our growth to create value in our business and for the patients we serve,” said Richard Pops, chief executive officer of Alkermes. “Alkermes is excited to have our operations based in Ireland, which we view as a gateway to the European Union and global pharmaceutical market.”

John Perry TD, Ireland’s Minister of State for Small Business, remarked, “Alkermes plc’s decision to establish its headquarters in Ireland is further demonstration of this country’s continued ability to attract companies, like Alkermes, in growth industries, to set up operations here. Today’s announcement showcases that Ireland is very much open for business and is an excellent location to host operations of multinational companies. The additional announcement of a new contract for the Athlone facility is an indication of its track record for successful innovation and high-quality manufacturing.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics